Orion Corporation
Pharmaceutical ManufacturingUusimaa, Finland1001-5000 Employees
Orion Corporation is a Nordic pharmaceutical company with a global footprint, focused on developing, manufacturing, and marketing medicines for humans and animals, as well as active pharmaceutical ingredients. Its portfolio comprises both proprietary and generic medicines and consumer health products, reflecting a diversified range of offerings. The company's R&D emphasizes oncology and pain, with proprietary therapies directed at cancer, respiratory, and neurological diseases. Based in Espoo, Uusimaa, Finland, Orion traces its operations to a long history in the sector, spanning more than a century. It serves international markets by bringing its products from development to distribution with a sizable global workforce. In 2026 it announced a collaboration with Bayer AG to develop Nubeqa, a prostate cancer drug, and expanded its Turku facilities to advance carbon-free production.